本页面由Tiger Trade Technology Pte. Ltd.提供服务

武田制药

18.52
-0.1600-0.86%
盘后:18.520.00000.00%19:30 EDT
成交量:292.51万
成交额:5,441.49万
市值:589.41亿
市盈率:-58.16
高:18.82
开:18.73
低:18.52
收:18.68
52周最高:19.10
52周最低:12.99
股本:31.83亿
流通股本:30.92亿
量比:1.11
换手率:0.09%
股息:0.63
股息率:3.41%
每股收益(TTM):-0.3184
每股收益(LYR):-0.3042
净资产收益率:-2.26%
总资产收益率:2.69%
市净率:1.23
市盈率(LYR):-60.87

数据加载中...

2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/06/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities